LEADER 04122nam  22007215  450 
001 9910298291803321
005 20200706035754.0
010   $a3-319-12283-5
024 7 $a10.1007/978-3-319-12283-0
035   $a(CKB)3710000000311636
035   $a(EBL)1968190
035   $a(OCoLC)897466509
035   $a(SSID)ssj0001407850
035   $a(PQKBManifestationID)11901072
035   $a(PQKBTitleCode)TC0001407850
035   $a(PQKBWorkID)11410879
035   $a(PQKB)11069944
035   $a(DE-He213)978-3-319-12283-0
035   $a(MiAaPQ)EBC1968190
035   $a(PPN)183153871
035   $a(EXLCZ)993710000000311636
100   $a20141202d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aEpilepsy Towards the Next Decade $eNew Trends and Hopes in Epileptology /$fedited by Pasquale Striano
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (243 p.)
225 1 $aContemporary Clinical Neuroscience,$x2627-535X
300   $aDescription based upon print version of record.
311   $a3-319-12282-7 
320   $aIncludes bibliographical references and index.
327   $aPreface -- Copy number variants and epilepsy: new emerging syndromes -- Mutations of ion channels in genetic epilepsies -- LGI1 dysfunction in inherited and acquired epileptic disorders -- Glioneuronal tumors and epilepsy: clinico-diagnostic features and surgical strategies -- Metabolic causes of epilepsy -- New insights into mechanisms underlying generalized reflex seizures -- Current status and future prospective of neuroimaging for epilepsy -- The complex relationship between epilepsy and headache and the concept of ictal epileptic headache -- Epilepsy and immune system: a tour around the current literature -- Novel molecular targets for drug-treatment of epilepsy -- Reproductive hormones in epilepsy therapy: from old promises to new hopes -- Neuromodulation for the treatment of drug-resistant epilepsy -- New radiosurgical paradigms to treat epilepsy using synchrotron radiation.
330   $a      A comprehensive collection of the most recent knowledge on the biological bases of various kinds of epilepsies and modern clinical approaches to their treatment. Epilepsy affects about 0.5-1% of the world's population (about 50,000,000 individuals) and the main goal of its treatment is to eliminate seizures without creating side effects.       Despite numerous advances in the treatment of epilepsy and the approval of several new antiepileptic drugs, about 30% of patients continue to experience recurrent seizures which are medically, physically, and/or socially disabling. The editor of this volume hopes that by bridging the gap between the fundamental biology of epilepsy and its clinical implications he might spur further research and treatment options.
410  0$aContemporary Clinical Neuroscience,$x2627-535X
606   $aNeurosciences
606   $aPsychiatry
606   $aNeurology 
606   $aClinical psychology
606   $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006
606   $aPsychiatry$3https://scigraph.springernature.com/ontologies/product-market-codes/H53003
606   $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001
606   $aClinical Psychology$3https://scigraph.springernature.com/ontologies/product-market-codes/Y12005
615  0$aNeurosciences.
615  0$aPsychiatry.
615  0$aNeurology .
615  0$aClinical psychology.
615 14$aNeurosciences.
615 24$aPsychiatry.
615 24$aNeurology.
615 24$aClinical Psychology.
676   $a610
676   $a612.8
676   $a616.8
676   $a616.89
702   $aStriano$b Pasquale$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298291803321
996   $aEpilepsy Towards the Next Decade$92500509
997   $aUNINA